Previous Close | 1.5600 |
Open | 1.5600 |
Bid | 1.4500 x 7200 |
Ask | 1.4800 x 7200 |
Day's Range | 1.4500 - 1.6500 |
52 Week Range | 1.2500 - 14.5500 |
Volume | |
Avg. Volume | 9,765,237 |
Market Cap | 393.889M |
Beta (5Y Monthly) | 1.83 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2100 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.08 |
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Market forces rained on the parade of Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders today, when...
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.